TORONTO, August 12, 2020 /CNW/ – Zenabis Global Inc. (TSX:ZENA) („Zenabis” or „company”) has announced a one-year supply contract for high-quality cannabis flowers with Canveda Inc. („Canveda”), a wholly owned subsidiary of MPX International Corporation (MPX International) or „MPXI,” a multinational cannabis company. Daniel Burns, Chairman of the Board of Directors, said: „We are pleased to expand our delivery relationships beyond Canada. This incremental supply agreement, and in particular the minimum mandatory delivery, continues to demonstrate both the quality of our cannabis production and our international mass delivery capacity. Under the supply agreement, ZenPharm will supply Farmako with quality Zenabis-grown medicinal cannabis flowers for distribution to medical cannabis patients in Germany. The agreement aims to facilitate the distribution of 1,500 kilograms of cannabis flowers by Farmako in Germany over a three-year period. Farmako will distribute the products to its established network of German pharmacies. The products will carry Farmakos branding, an important step in building awareness and loyalty to physicians, pharmacists and patients. The products first contain a very effective THC flower and the balanced THC and CBD flower, two categories of products that management thinks, are the most in demand in Germany. Deliveries to Farmako are expected to begin in November 2020. „MPX International Corporation is pleased to be able to count on Zenabis Ltd if we continue to supply high quality Canadian cannabis as we develop different market opportunities,” says Michael Arnkvarn, COO of MPXI Canadian Operations; „Zenabis has shown that they are very proactive and able to meet our desires.” ZenPharm, Managing Director of Angele Azzopardi, said: „Our team is incredibly proud to continue this operation.
This agreement demonstrates not only Zenabis` commitment, but also the transatlantic synergy of Zenabis, ZenPharm in the supply of cannabis-based medical products in Europe. We look forward to developing our relationship with Farmako, especially as more conventional forms of medical cannabis products are being marketed. About Farmako GmbHFarmako GmbH is a pharmaceutical wholesaler based in Frankfurt-on-Main. The company focuses on the distribution of medical cannabis in pharmacies to ensure the supply of cannabis to patients and to bridge the gap between the supply and demand of medical cannabis. Farmako plans to extend its business model to other European countries, with an appropriate legal basis, in order to achieve its goal of being the first European distributor of medical cannabis. The company has been marketing medical cannabis in pharmacies in Germany since March 2019 and is fully licensed in the UK to begin distribution in 2020. Farmako is a wholly-paid subsidiary of AgraFlora Organics International Inc. For more information, see: www.farmako-global.com/.